Agilent Technologies, INC 8-K filings

Agilent Technologies has completed a $600 million private placement of 4.900% senior unsecured notes maturing in 2032.

Agilent Technologies announced the appointment of Michael Buckner as its new Chief Legal Officer, effective May 4, 2026, succeeding Bret DiMarco.

Agilent Technologies files an amendment to a previous 8-K report to correct a filing header error, clarifying the disclosure pertains to executive transition arrangements.

Agilent Technologies stockholders approved a phased declassification of its Board of Directors and adopted new bylaws, enhancing corporate governance.

Agilent Technologies, Inc. announced that Rodney Gonsalves, Vice President, Corporate Controller, and Principal Accounting Officer, will retire in January 2027.

Agilent Technologies delivered solid first-quarter fiscal year 2026 financial results, reporting $1.80 billion in revenue and raising its full-year reported revenue and non-GAAP EPS guidance.

Agilent Technologies reported strong fourth-quarter and full fiscal year 2025 financial results, exceeding revenue guidance and initiating optimistic fiscal year 2026 outlook.

Agilent Technologies Inc. announced the appointment of Adam S. Elinoff, a seasoned finance executive from Amgen, as its new Chief Financial Officer, effective November 17, 2025.

Agilent Technologies reported strong third-quarter fiscal year 2025 financial results, exceeding revenue guidance and raising its full-year outlook.

Agilent Technologies, Inc. amends its 8-K filing to disclose the compensation package for interim Chief Financial Officer Rodeny Gonsalves, including a bi-weekly salary stipend and a $1 million restricted stock unit grant.

Agilent Technologies announced the resignation of its Senior Vice President and Chief Financial Officer, Robert W. McMahon, effective July 31, 2025, and the appointment of Rodney Gonsalves as interim CFO.

Agilent Technologies Inc. announced robust second-quarter fiscal year 2025 financial results, with revenue growth and increased non-GAAP earnings per share, attributing success to its 'Ignite Transformation' strategy despite a significant decline in GAAP net income.

Agilent Technologies expands its Board of Directors with the addition of Pascal Soriot and Judy Gawlik Brown, bringing extensive experience in the pharmaceutical, biotechnology, and healthcare sectors.

Henrick Ancher-Jensen, Senior Vice President at Agilent Technologies, has resigned effective June 1, 2025, to pursue another opportunity.

Heidi Kunz, a member of Agilent Technologies' Board of Directors, has announced her resignation, effective May 21, 2025.

Agilent Technologies successfully held its annual meeting, electing directors, approving executive compensation, ratifying the accounting firm, and approving amendments to the certificate of incorporation.

Agilent Technologies recasts its financial segments to align with its new market-focused, customer-centric strategy, combining and moving divisions to form three reportable segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.

Agilent Technologies announces first-quarter fiscal year 2025 results with revenue of $1.68 billion, representing 1.4% reported growth and 1.2% core growth, while maintaining full-year outlook.

Agilent Technologies has restructured its operations into three new reportable segments: Life Sciences and Diagnostics, Applied Markets, and Agilent CrossLab, and has provided historical financial data for these segments.

Agilent Technologies reported a slight revenue increase but a decrease in GAAP earnings for the fourth quarter of fiscal year 2024, while also announcing a new organizational structure.

Agilent Technologies has announced a reorganization into three new business groups to better align with its end markets and customers, effective immediately.

Agilent Technologies successfully completed a $1.2 billion offering of senior notes, split between 2027 and 2034 maturities.

Agilent Technologies has entered into an agreement to issue $1.2 billion in senior notes to fund general corporate purposes.

Agilent Technologies has refiled certain financial statements to reflect a change in its operating segments, moving its cell analysis business to the diagnostics and genomics segment.

Agilent Technologies reported better-than-expected financial results for the third quarter of fiscal year 2024, leading to an upward revision of its full-year revenue and earnings guidance.

Agilent Technologies reported a revenue decline in the second quarter of fiscal year 2024, while also announcing a new $2 billion stock repurchase program.

Agilent Technologies has amended its previous 8-K filing to disclose the compensation package for its newly appointed CEO, Padraig McDonnell.

Hans E. Bishop has stepped down from Agilent Technologies' board of directors, effective May 23, 2024, after serving since 2017.

Agilent Technologies has appointed Padraig McDonnell as its new CEO, effective May 1, 2024, succeeding Mike McMullen as part of a planned leadership transition.

Agilent Technologies successfully held its annual meeting, electing four directors and approving several key proposals, including executive compensation and auditor ratification.